Effects of <i>CALR</i>-Mutant Type and Burden on the Phenotype of Myeloproliferative Neoplasms
Somatic <i>CALR</i> mutations occur in approximately 70% of patients with <i>JAK2</i> V617F-negative essential thrombocythemia (ET) and primary myelofibrosis (PMF). We evaluated the effects of the <i>CALR</i> mutant type and burden on the phenotype of <i>CAL...
Main Authors: | Hyun-Young Kim, Yujin Han, Jun Ho Jang, Chul Won Jung, Sun-Hee Kim, Hee-Jin Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/12/11/2570 |
Similar Items
-
Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice
by: Keiji Minakawa, et al.
Published: (2021-03-01) -
A germline JAK2 exon12 mutation and a late somatic CALR mutation in a patient with essential thrombocythemia
by: Zhuanghui Hao, et al.
Published: (2024-01-01) -
Impact of CALR and JAK2V617F Mutations on Clinical Course and Disease Outcomes in Essential Thrombocythemia: A Multicenter Retrospective Study in Turkish Patients
by: Zehra Narlı Özdemir, et al.
Published: (2024-03-01) -
FREQUENCY OF CALR GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
by: Sana Latif, et al.
Published: (2020-04-01) -
Integration of Molecular Information in Risk Assessment of Patients with Myeloproliferative Neoplasms
by: Giuseppe G. Loscocco, et al.
Published: (2021-08-01)